Virtual Reality a Novel Screening and Treatment Aid in Attention Deficit Disorder

Status

Completed

Phases

Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00364702

Enrollment

Registered

2006-08-16

Start date

2006-08-31

Completion date

2007-07-31

Last updated

2011-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ADHD

Keywords

Virtual Reality, ADHD, Methylphenidate

Brief summary

Using a virtual reality program in screening and treatment of ADHD.

Detailed description

Virtual Reality is a novel program designed to imitate a real classroom environment including various distractions. It includes a head monitor to track eye movements Children aged 10-20 years with ADHD will use the program with and without methylphenidate(1 mg/kg). Their results will be compared to a control group. Parental consent will be obtained.

Interventions

DRUGmethylphenidate

Study design

Allocation

NON_RANDOMIZED

Intervention model

FACTORIAL

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

10 Years to 20 Years

Healthy volunteers

Yes

Inclusion criteria

Clinical diagnosis of ADHD-DSM4 criteria AGE 10-20 YEARS normal neurological examination IQ\>80

Exclusion criteria

ABNORMAL NEUROLOGICAL STATUS

Design outcomes

Primary

Measure	Time frame
Virtual Reality program test results	—

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026